ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,033Medicare Part D Prescriptions Filled, Including Refills

Rank: 195 out of 551

$435K Total Retail Price of All Prescriptions

Rank: 125 out of 551

517 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 7,511 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 642 547 1 1
METFORMIN HCL 351 285 2 2
LISINOPRIL 298 231 3 14
GABAPENTIN 285 213 4 3
OMEPRAZOLE 280 246 5 7
LOSARTAN POTASSIUM 256 221 6 6
SYNTHROID 230 213 7 11
AMLODIPINE BESYLATE 218 197 8 4
LOSARTAN-HYDROCHLOROTHIAZIDE 189 173 9 10
TRAMADOL HCL-ACETAMINOPHEN 168 105 10 18
LEVOTHYROXINE SODIUM 163 132 11 9
GLIMEPIRIDE 133 117 12 16
METOPROLOL TARTRATE 130 128 13 17
METOPROLOL SUCCINATE 124 123 14 23
SERTRALINE HCL 124 122 14 43
FUROSEMIDE 117 79 16 13
CLOPIDOGREL 111 102 17 30
WARFARIN SODIUM 110 83 18 46
ZOLPIDEM TARTRATE 105 54 19 27
RANITIDINE HCL 104 86 20 8
EVISTA 102 100 21 52
ATENOLOL 95 84 22 12
ADVAIR DISKUS 94 68 23 97
ENALAPRIL MALEATE 92 72 24 5
ATORVASTATIN CALCIUM 91 77 25 29
CARVEDILOL 90 66 26 22
DOXAZOSIN MESYLATE 87 78 27 25
LANTUS 86 62 28 28
ISOSORBIDE MONONITRATE ER 80 68 29 21
RAMIPRIL 77 67 30 53
GLIPIZIDE 76 70 31 20
PANTOPRAZOLE SODIUM 74 68 32 36
PLAVIX 72 67 33 33
VERAPAMIL ER 71 45 34 39
TAMSULOSIN HCL 70 59 35 38
LANSOPRAZOLE 69 63 36 72
DICLOFENAC POTASSIUM 68 39 37 45
HYDROCHLOROTHIAZIDE 67 51 38 15
ALENDRONATE SODIUM 60 54 39 19
DONEPEZIL HCL 59 57 40 50
SINGULAIR 59 32 40 58
HUMULIN N 57 46 42 47
CYMBALTA 55 34 43 105
GLYBURIDE-METFORMIN HCL 54 43 R 44 48
CLOTRIMAZOLE-BETAMETHASONE 50 34 45 49
CIPROFLOXACIN HCL 50 39 45 54
SUCRALFATE 50 47 45 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.